3DHISTECH and Epredia open pathology innovation incubator to accelerate advancements in cancer diagnostics

Two leading pathology and diagnostics companies, 3DHISTECH of Hungary and Epredia, a member of PHC Group (headquartered in Japan), announce the opening of the Pathology Innovation Incubator in Budapest to develop methods and equipment for faster and more precise diagnosis of cancer and tumor lesions.

NCCN releases new resources to improve quality of life for people with cancer

The National Comprehensive Cancer Network® (NCCN®) is announcing new resources focused on improving quality of life for people with cancer while making sure care planning

October 30, 2023

EULAR develops new classification criteria for hand osteoarthritis

At present, classifying hand osteoarthritis (OA) is based on clinical findings, and available tools are not able to distinguish between certain phenotypes.

June 7, 2024

New discovery could reduce arsenic contamination in water

A study led by the University of Bristol shedding new light on how arsenic can be made less dangerous to humans has the potential to

October 30, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.